The Drug-Induced Respiratory Disease Website

XIV. Pleural involvement

XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)

XX. Vasculitis

XX.c Vascultis (pulmonary, extrathoracic or systemic) - ANCA status unknown or negative

XXI. Mediastinal involvement/injury

XXI.a Lymphadenopathy (intrathoracic)

XXII. Acute respiratory/cardiorespiratory failure

XXII.b Acute lung injury - ARDS

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a Pneumonitis (ILD)

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.f Diffuse alveolar damage (DAD) imaging pattern

XXIX. Small airway involvement

XXIX.d Cough (lone)

XXX. Imaging features

XXX.b Imaging: A miliary pattern (diffuse random micronodules)

XXX. Imaging features

XXX.n Imaging: A 'tree-in-bud' pattern

XXXVI. Autoimmune syndromes - Systemic reactions or conditions

XXXVI.h Myasthenia gravis - Myasthenic-like syndrome

XXXVI. Autoimmune syndromes - Systemic reactions or conditions

XXXVI.i Guillain-Barré (or GB-like) syndrome (w/wo ARF)

XXXVI. Autoimmune syndromes - Systemic reactions or conditions

XXXVI.k Multiple organ dysfunction/failure (MODS/MOF)

XXXVIII. Miscellaneous - Varia

XXXVIII.a Upper airway obstruction other than angioedema or hematoma

XXXVIII. Miscellaneous - Varia

XXXVIII.k Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)

X. Pulmonary edema

X.b Pulmonary edema, noncardiogenic (NCPE)

XVI. Hemorrhage - Bleeding - Hematoma(s)

XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)

XXII. Acute respiratory/cardiorespiratory failure

XXII.b Acute lung injury - ARDS

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.k Pulmonary infiltrates

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.ag Chemical (toxic) pneumonitis

XXVIII. Large airway involvement

XXVIII.b Epiglottitis

XXVIII. Large airway involvement

XXVIII.c Tracheal injury

XXIX. Small airway involvement

XXIX.l Bronchiolitis (a clinical-imaging pattern suggestive of)

XXIX. Small airway involvement

XXIX.m Obstructive airway dysfunction (see also IVc, XVx)

XXIX. Small airway involvement

XXIX.n Reactive airway dysfunction syndrome (RADS)

XXX. Imaging features

XXX.k Imaging: Centrilobular micronodules (can be diffuse)

XXX. Imaging features

XXX.n Imaging: A 'tree-in-bud' pattern

XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)

XXXIII.j Path: Pulmonary edema

XXXVI. Autoimmune syndromes - Systemic reactions or conditions

XXXVI.r Anti-GBM-related pneumorenal syndrome and DAH (Goodpasture) or flare of